Valuation: OrganiGram

Market Cap 180M 128M 112M 105M 95.9M 12.32B 183M 1.24B 485M 6.06B 480M 470M 20.95B P/E 2026 *
9.85x
P/E 2027 * 32x
Enterprise Value 180M 128M 112M 105M 95.9M 12.32B 183M 1.24B 485M 6.06B 480M 470M 20.95B EV / Sales 2026 *
0.53x
EV / Sales 2027 * 0.41x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 128M
-1.03%+0.52%+37.86%+221.67% 223M
+2.15%-1.04%+5.56%+106.52% 130M
-0.25%-11.09%-9.72%-11.17% 80.1M
-6.02%-7.14%-2.50%-40.00% 84.23M
+1.94%+3.08%-43.06%-50.75% 51.28M
Average -1.18%-3.42%-2.37%+45.25% 113.77M
Weighted average by Cap. -1.25%-2.12%+10.48%+99.19%

Financials

2026 *2027 *
Net sales 340M 241M 212M 197M 181M 23.22B 345M 2.34B 914M 11.42B 905M 886M 39.47B 441M 313M 275M 256M 235M 30.14B 448M 3.04B 1.19B 14.82B 1.18B 1.15B 51.24B
Net income 18.88M 13.4M 11.77M 10.95M 10.05M 1.29B 19.17M 130M 50.79M 635M 50.32M 49.23M 2.19B 6.53M 4.64M 4.07M 3.79M 3.48M 447M 6.63M 44.98M 17.57M 220M 17.41M 17.03M 759M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-